Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Apr 2022 for Gensight Biologics S.A., €117k. Read the official filing
Filing timeline
BuySaleBernard Gilly
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +5.1%Entry €2.29 · Close at T+365 €2.41
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Bernard Gilly: trading record in brief
One trade, one date: on 11 April 2022, Bernard Gilly disclosed an open-market purchase of €117k in Gensight Biologics S.A. No broader history exists yet. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Bernard Gilly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
50,000 shares@ €2.3425100.0% of flowActionEuronext ParisISIN FR00131839852022DD835024
Canonical exit: 6 Jul 2022 (T+90)
1 of 1 declaration
